Lane & Hall [1] contribute to a growing literature on the public safety consequences of legalizing the sale of cannabis for recreational use. The policy importance of estimating the effects of legalization on public safety measures, such as traffic fatalities, is growing as more US states legalize and as policymakers grapple with regulating in an environment of scant evidence with mixed conclusions. Hansen, Miller & Weber [2] found no significant effect of cannabis legalization on traffic fatalities in Washington and Colorado, the first two states to legalize recreational sales, while Lane & Hall found a short-term increase in traffic fatalities following legalization in their analysis of states that legalized recreational sales and their neighbors [1] . Isolating the causal impact of legalization on traffic fatalities is challenging, as Hansen and colleagues note, due to changes in reporting and testing regimes muddling estimation and the tenuous link between detected cannabis use and impairment [2] .
Legalizing the sale of recreational cannabis affects enforcement. We expect decreases in arrests in states that legalize recreational cannabis, as most people possessing cannabis would now be within state law. In Colorado, for example, cannabis-related arrests decreased by 52% between 2012 and 2017 [3] . At the same time, legalizing recreational use adds to the enforcement and regulation burden of roadways, notably interstate trafficking and drugged driving.
INTERSTATE FLOWS
Legalization appears to have had a mixed effect on the black market in states that have legalized. Prices have fallen in these states (some substantially), putting downward pressure on black-market revenues. Meanwhile, reduced enforcement of growers has increased production volumes for export so much that some black-market growers might be doing better than before. The most recent data from the California Department of Food and Agriculture show state-wide production exceeding demand by a factor of six [4] . Much of that excess is expected to make its way east. Oregon's overproduction is similarly stark; a recent Oregon-Idaho High Intensity Drug Trafficking Area report estimates that, as of 2018, nearly 70% of cannabis produced for the recreational market was unsold [5] . The Oregon supply glut has prompted introduction of Senate Bill 582, which would authorize the state to export cannabis to contiguous states where cannabis is legal [6] . Notably, if SB 582 passed it would put the state in the crosshairs of federal enforcement agencies, as interstate transport of cannabis remains a federal crime. Of course, all state-legal cannabis possession and commerce remain federal crimes, but the federal government has issued-and rescinded-guidance tolerating limited and regulated intrastate commerce [7] . At this point in time, US Department of Justice policy is unclear, but state-legal commerce continues apace.
Cannabis legalization has been a boon to interstate traffickers. We can expect increases in trafficking between legal and non-legal states, as well as between legal states. Cannabis regulators should heed lessons from the large markets for illicit cigarettes in the United States, which are driven in part by differences in state and local taxes. It is estimated that more than half the cigarettes consumed in New York State and nearly half those consumed in Arizona are smuggled from lower-tax states [8] . Cannabis is easier to move than cigarettes (by weight), and large amounts (flower or concentrate) can be moved in comparatively small containers, so interstate enforcement will pose an even greater challenge.
DRUGGED DRIVING
Roadside testing for impairment under the influence of alcohol is easy; the large and unwieldy 'drunk-o-meter' of the 1930s has given way to breathalyzers that can reliably detect recent use [9] . All states have per se standards for alcohol intoxication and the state is not required to prove that alcohol has impaired the driver, only that the driver's blood-alcohol content exceeded the legal limit. Testing for cannabis is much more complicated because of how tetrahydrocannabinol (THC), the main psychoactive component in cannabis, metabolizes; evidence of use, even recent use, does not necessarily indicate current impairment. New tests are emerging for any recent use, but what should qualify as impairment continues to be debated.
